www.pharmablog.nl
Weblog met nieuws over de pharmaceutische industrie
Benicar (olmesartan): Ongoing Safety Review
Author: admin13 Jun
Audience: Cardiology, Internal Medicine
ISSUE: FDA is evaluating data from two clinical trials in which patients with type 2 diabetes taking the blood pressure medication, Benicar (olmesartan), an angiotensin II receptor blocker, had a higher…
Audience: Cardiology, Internal Medicine
ISSUE: FDA is evaluating data from two clinical trials in which patients with type 2 diabetes taking the blood pressure medication, Benicar (olmesartan), an angiotensin II receptor blocker, had a higher…
Leave a reply
You must be logged in to post a comment.